Part 2 of The Psychedelic Syndicate exposes the compromised foundation of PSFC's influence network — from the abuse scandals that undermined their preferred therapy model, to undisclosed ties with the sole FDA advisory committee member who voted unequivocally for MDMA approval. 

Part 3 of The Psychedelic Syndicate exposes how Silicon Valley's "move fast and break things" mentality infected psychedelic therapy, creating a culture where leaders rationalized patient harm as unavoidable for progress and ultimately embraced Trump administration officials who promised regulatory shortcuts.

Part 4 of The Psychedelic Syndicate reveals PSFC’s strategy to manufacture spiritual and moral authority through academic capture — even as some members align with far-right ideologies that deepen the very crises psychedelics are meant to heal.

In this episode, we respond to Hamilton Morris' claims that we are DEA informants and that we colluded with the FDA to get Lykos Therapeutics' MDMA therapy application rejected.

In this episode, we examine previous smear campaigns against us related to our reporting on the Church of Psilomethoxin and Martin Ball, as well as false claims about who funds us and why.

In this episode, we continue the conversation about our funding and explore Hamilton Morris' conspiratorial claims about the company Usona.

In this episode, we continue the conversation about our funding and explore Hamilton Morris' conspiratorial claims about the company Usona.